Product Introduction:
Mignar MF Tablet combines Metformin, a biguanide that decreases hepatic glucose production and improves insulin sensitivity, with Miglitol, an alpha-glucosidase inhibitor that delays the absorption of carbohydrates from the intestine. This combination effectively controls both fasting and postprandial blood glucose levels in patients with type 2 diabetes.
Uses:
-
Type 2 Diabetes Mellitus
-
Helps in maintaining glycemic control in patients uncontrolled on monotherapy
-
Especially useful in patients with postprandial hyperglycemia
Benefits:
-
Controls blood sugar by multiple mechanisms
-
Reduces risk of diabetic complications
-
Helps regulate post-meal glucose spikes
-
Improves insulin sensitivity
Composition (per tablet):
-
Metformin Hydrochloride – 500 mg
-
Miglitol – 25 mg
Side Effects:
Common:
-
Flatulence
-
Abdominal discomfort
-
Diarrhea
-
Nausea
-
Metallic taste
Rare but serious:
-
Lactic acidosis (from Metformin – very rare but serious)
-
Severe gastrointestinal upset (if taken incorrectly)
-
Hypoglycemia (rare when used alone)
Safety Advice:
-
Take with meals to reduce stomach discomfort
-
Regular monitoring of blood sugar levels is essential
-
Avoid alcohol consumption (increases risk of lactic acidosis)
-
Not recommended in patients with kidney or liver dysfunction
-
Not to be used in type 1 diabetes or diabetic ketoacidosis
-
Store in a cool, dry place away from sunlight
-
Keep out of reach of children
